Advanced Filters
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
noise

Found 2,823 clinical trials

f formal-investigator1

VAXX Formal Django Update

Details here

100 years and younger All Phase 3

Evaluation of an Ostomy Leakage Detection System

This study will evaluate the safety and efficacy of an ostomy leakage detection system.

18 years and older All Phase N/A
J Johnny Jenkins

API Trial-T1

API Trial-T1

99 years and younger All Phase N/A
T Test3 user3

PCSK9i in AAA123

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

99 years and younger All Phase N/A
T Test3 user3

PCSK9i in AAA123

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

99 years and younger All Phase N/A
E Edward Stadtmauer

Testing Trial without NCT (NCT 2)

Testing Trial without NCT (NCT 2)

100 years and younger All Phase 1
S Suhrutha Bushan

A Study of ADRX-0405 in Subjects with Select Advanced Solid Tumors

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0405 in patients with select advanced solid tumors.

18 years and older All Phase 1
U UAT Investigator 1

UAT test Communication Study

Study Overview UAT

90 years and older Male Phase N/A
B Boehringer Ingelheim

A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics and pharmacodynamics of BI 3731579 in healthy volunteers following administration of multiple rising doses per day over 15 days.

18-55 years All Phase 1

Prophylactic Peptide Vaccine in Advanced ALK+ NSCLC

The purpose of this study is to evaluate the safety of a cancer peptide vaccine to prevent or delay acquired resistance in advanced ALK+ lung cancer patients currently on ALK targeted therapy.

18 years and older All Phase 1/2

Simplify language using AI